SCHEMBL21692589

SCHEMBL21692589

N#Cc1ccc2sc3ccc(-c4cc(-c5ccccc5C#N)cc(-c5cccc6c5sc5ccccc56)c4)cc3c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
ESR2 Q92731 1/20 0.35
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
PRKDC P78527 1/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
HSD17B10 Q99714 3/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA2 P47869 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
PARP14 Q460N5 1/20 0.33
AR P10275 1/20 0.32
PRMT5 O14744 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21692576 1.00 ALOX5 (0.44) ALOX5ESR2PIM1PIM3PIM2
SCHEMBL21692584 0.98 ALOX5 (0.41) ALOX5ESR2PIM1PIM3PIM2
SCHEMBL21692402 0.96 ALOX5 (0.43) ALOX5ESR2PIM1PIM3PIM2
SCHEMBL21692399 0.96 ALOX5 (0.43) ALOX5ESR2PIM1PIM3PIM2
SCHEMBL21692608 0.95 ALOX5 (0.41) ALOX5ESR2PIM1PIM3PIM2
SCHEMBL21693100 0.94 ALOX5 (0.49) ALOX5ESR2PRKDCCYP1A2CYP3A4
SCHEMBL21693094 0.94 ALOX5 (0.49) ALOX5ESR2PRKDCCYP1A2CYP3A4
SCHEMBL21691647 0.94 ALOX5 (0.46) ALOX5ESR2PRKDCGABRA1GABRG2
SCHEMBL21691682 0.94 ALOX5 (0.44) ALOX5PIM1PIM3PIM2PRKDC
SCHEMBL21691557 0.93 ESR2 (0.39) ESR2CYP1A2CYP3A4HSD17B10GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885ESR2 77/4885PIM1 3916/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885ESR2 77/4885PIM1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.